AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
1-Year Return
13.43%
This Quarter Return
-4.57%
1 Year Return
+13.43%
3 Year Return
+69.62%
5 Year Return
+161.48%
10 Year Return
+94.79%
AUM
$12.2B
AUM Growth
-$499M
(-3.9%)
Cap. Flow
-$543M
Cap. Flow
% of AUM
-4.45%
Top 10 Holdings %
Top 10 Hldgs %
52.02%
Holding
832
New
248
Increased
200
Reduced
214
Closed
170
Top Buys
Top Sells
| 1 |
WPZ
WILLIAMS PARTNERS L.P. COM UTS REPTG L.P. INT
WPZ
|
$434M |
| 2 |
Lumen
LUMN
|
$376M |
| 3 |
iShares Select Dividend ETF
DVY
|
$284M |
| 4 |
CLR
CONTINENTAL RESOURCES INC.
CLR
|
$283M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
$147M |
Sector Composition
| 1 | Energy | 71.17% |
| 2 | Materials | 2.11% |
| 3 | Consumer Discretionary | 1.46% |
| 4 | Healthcare | 1.42% |
| 5 | Industrials | 1.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
CenterPoint Energy
CNP
$24.5B
| $1.93M | 0.02% |
94,625
+15,083
| +19% | +$308K |
|
|
NGD
152
New Gold Inc
NGD
$4.86B
| $1.9M | 0.02% |
561,696
+113,239
| +25% | +$384K |
|
153
First Majestic Silver
AG
$4.43B
| $1.9M | 0.02% |
350,518
-22,777
| -6% | -$123K |
|
154
Host Hotels & Resorts
HST
$12.1B
| $1.89M | 0.02% |
93,771
+716
| +0.8% | +$14.4K |
|
155
Essex Property Trust
ESS
$17B
| $1.82M | 0.01% |
7,919
+78
| +1% | +$17.9K |
|
|
GEVA
156
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $1.8M | 0.01% |
+18,432
| New | +$1.8M |
|
|
IPXL
157
DELISTED
Impax Laboratories, Inc.
IPXL
| $1.66M | 0.01% |
+35,425
| New | +$1.66M |
|
158
Neurocrine Biosciences
NBIX
$13.9B
| $1.65M | 0.01% |
+41,481
| New | +$1.65M |
|
159
Deere & Co
DE
$128B
| $1.62M | 0.01% |
18,423
-12,207
| -40% | -$1.07M |
|
160
Acadia Pharmaceuticals
ACAD
$4.3B
| $1.62M | 0.01% |
+49,565
| New | +$1.62M |
|
161
Pacira BioSciences
PCRX
$1.2B
| $1.6M | 0.01% |
+18,035
| New | +$1.6M |
|
162
Archer Daniels Midland
ADM
$29.8B
| $1.6M | 0.01% |
33,742
-9,248
| -22% | -$438K |
|
163
SL Green Realty
SLG
$4.25B
| $1.55M | 0.01% |
12,428
+277
| +2% | +$34.4K |
|
|
HZNP
164
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.53M | 0.01% |
+59,066
| New | +$1.53M |
|
|
ASPX
165
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
| $1.52M | 0.01% |
+15,173
| New | +$1.52M |
|
|
SSRI
166
DELISTED
Silver Standard Resources
SSRI
| $1.51M | 0.01% |
333,980
-13,898
| -4% | -$63K |
|
167
Macerich
MAC
$4.68B
| $1.47M | 0.01% |
17,395
+192
| +1% | +$16.2K |
|
168
Realty Income
O
$53.3B
| $1.42M | 0.01% |
28,458
+332
| +1% | +$16.6K |
|
169
Kimco Realty
KIM
$15.4B
| $1.37M | 0.01% |
50,907
+449
| +0.9% | +$12.1K |
|
170
Celldex Therapeutics
CLDX
$1.51B
| $1.34M | 0.01% |
+3,210
| New | +$1.34M |
|
171
Chevron
CVX
$318B
| $1.34M | 0.01% |
12,734
-2,607
| -17% | -$274K |
|
172
Ligand Pharmaceuticals
LGND
$3.27B
| $1.3M | 0.01% |
+26,975
| New | +$1.3M |
|
173
CF Industries
CF
$13.6B
| $1.26M | 0.01% |
22,180
+5,235
| +31% | +$297K |
|
|
CLVS
174
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.26M | 0.01% |
+16,946
| New | +$1.26M |
|
175
Federal Realty Investment Trust
FRT
$8.71B
| $1.25M | 0.01% |
8,479
+190
| +2% | +$28K |
|